1 / 19

Alternative Careers in the Pharmaceutical and Biotechnology Industry

Alternative Careers in the Pharmaceutical and Biotechnology Industry. Martin A. Wasserman, Ph.D. January 14, 2014 UTMB Career Development Workshop. TOP PHARMA/BIOTECH COMPANIES. Pfizer Merck GlaxoSmithKline (GSK) Novartis Bristol-Myers Squibb (BMS) Hoffmann-La Roche (Roche) Eli Lilly

gannon
Download Presentation

Alternative Careers in the Pharmaceutical and Biotechnology Industry

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Alternative Careers in the Pharmaceutical and Biotechnology Industry • Martin A. Wasserman, Ph.D. • January 14, 2014 • UTMB Career Development Workshop

  2. TOP PHARMA/BIOTECH COMPANIES • Pfizer • Merck • GlaxoSmithKline (GSK) • Novartis • Bristol-Myers Squibb (BMS) • Hoffmann-La Roche (Roche) • Eli Lilly • Abbott • Sanofi • Amgen, Genentech, Biogen

  3. THE WORLD IS CHANGING… AND SO MUST WE • Pharmaceutical and biotechnology company M&A are increasing competitive pressure, e.g., Sanofi, GSK, Merck, Pfizer, Novartis, BMS, AZ, HLR • Industry trends require key decision points, e.g., milestones and Go/No Go criteria • R&D expenditures have dramatically increased • Longer cycle times across the value chain • Generics have initiated price pressures • Globalization of markets

  4. THE PHARMA AND BIOTECH INDUSTRY • Americans spend > $320B/year on medicines • For-profit, highly government-regulated business which innovatively discovers, tests, manufactures, and distributes a wide range of novel, safe, effective and quality-controlled medicines to prevent, treat and cure human diseases (a noble profession) • Technically complex, risky, costly, and regulated industry • Creates jobs (employs > 300,000 workers WW) and invests billions in R&D • Takes risks on unknown opportunities for potential “breakthrough blockbusters”; highly rewarding • Orchestrates project progression across the Value Chain

  5. INDUSTRY VS. ACADEMIA • Less differences and more similarities • Long hours and much is expected • Expectations to advance science, innovation, and to foster career growth are similar; personal accountability • Novelty and scientific freedom are encouraged • Mentors and supervisors encourage collegiality (“Team Membership”), consistent productivity, and communication • Regular feedback on performance • Job security linked to performance and funding • “Publish or perish” pertains to both • Flexibility and adaptability are imperative in the industry; expect and conform to change

  6. PHARMACEUTICAL INDUSTRYMYTHS AND MISCONCEPTIONS • PhDs and MDs inferior to academic counterparts • No publishing or meeting presentations required • Only perform work as instructed by supervisors • No academic adjunct appointments or external collaborations permitted • Keep breakthrough ideas to yourself • No novel proposal (“grant”) writing expected • Unlimited funds to do everything • No opportunities to transfer to non-bench jobs

  7. PHARMACEUTICAL INNOVATION • Assessed at time of Market introduction • Efficacy for a disease for which no drug is presently available • Novelty is competitive and time-related • Means “truly original”…not yet reduced to practice • Should improve the practice of medicine • Discovery of new approaches (Scientific Innovation), improves QoL or convenience for the patient, or improved formulations • Needs to be critically reassessed at each stage of the Development Process

  8. DISCOVERY RESEARCH MISSION AND STRATEGY • To rapidly discover novel, innovative, breakthrough drug candidates to treat diseases using cutting-edge technologies • To utilize early exploratory efforts to identify novel targets • To utilize state-of-the-art assay formats to identify “hits and leads” • Wherever possible, leverage “common mechanism” approaches to be opportunistic andsynergistic to increase productivity and to reduce cycle time in pursuing a diverse set of targets • To recognize failing compounds EARLY (“kill early, kill often”) and conduct quick “proof-of-concept” studies

  9. Toxico- genomics Chemical Genomics Pharmaco-genomics Evaluation of Lead Drug Candidates Manufacturing Development Actives, Hits, Lead Compounds Evaluation of drug efficacy Manufacturing Functional Genomics Clinical Trials Assay Development Process Development PK Target Identification & Validation Safety HTS Quality Control NDA Clinical Evaluation (safety, efficacy) and new drug application Medicinal Chemistry Establish role of gene in biology and disease THE DISCOVERY PROCESS 4 5 3 Genomic research Launch 2 Gene sequencing Microarrays Proteomics 6 Personalized Medicine 1

  10. SIGNIFICANT ADVANCES IN DRUG DESIGN • Identification of new molecular targets • Cloning of human receptors, enzymes, ion channels for structural elucidation of binding sites • Structural analysis of drugs with their binding sites, e.g., X-ray crystallography, NMR • Proprietary libraries of >107 chemical structures • Combinatorial chemistry techniques for rapid synthesis of selected drugs and related analogues • Automated HTPS for SAR (>105 compounds/week)

  11. REASONS DRUG CANDIDATES FAIL IN CLINICAL DEVELOPMENT • Toxicity- 2% • Lack of efficacy- 31% • The market- 6% • Poor biopharmaceutical properties, e.g., formulation, pharmacokinetics, ADME- 41% • Note: For every 20 compounds entering Phase I clinical trials, only 1 may become a marketed drug!

  12. KEY VALUES AND OPERATING PRINCIPLES • Urgency (focus on priorities, speedy delivery, flexibility, problem solving) • Creativity (innovation, originality, new hypotheses & targets, thinking “out-of-the-box”) • Courage (tenacity, decisiveness, tough decisions) • Empowerment (personal accountability; responsibility) • Teamwork (networking, partnership, sharing information, interactive) • Integrity (ethical standards, honesty & fairness) • Respect (trust, openness, listening, value diversity)

  13. WHAT COMPANIES LOOK FOR • Candidates who: • Are driven and motivated • Are ambitious • Are risk takers • Can follow instructions and take directions • Can work independently and as a Team Member • Can cope with stress and failure • Have the ability to manage and resolve conflict

  14. SOME CORE SKILLS IN THE PHARMACEUTICAL INDUSTRY • Pharmacology, Anatomy & Physiology • Molecular and Cellular Immunology, Genomics • Cellular and Molecular Biology • Biochemistry and Enzymology • Pathology & Toxicology • Animal Model Development, Drug Delivery, Formulations • Medicinal, Combinatorial, Analytical, Process Chemistry • ADME, Pharmacokinetics • Biostatistics, Statistical Analysis • Scientific & Medical Intelligence, Communication • Data & Knowledge Management • Networking, Opportunity Identification

  15. REQUISITE COMMUNICATION SKILLS • Verbal Presentations: • Authoritative and Persuasive • Team, Department, and Corporate • National and International Meetings, • Conferences, and Symposia • Written Publications: • Internal Technical and Final Reports • Abstracts and Peer-Reviewed Manuscripts • Invited Reviews and Book Chapters • Research Feasibility Proposals (“Grants”)

  16. DIVERSE CAREER OPPORTUNITIES I • Drug Discovery and Design; Innovation Strategy and • Implementation • Preclinical Research and Biomarker Development • Patents, Intellectual Property (IP) • Non-Clinical Analytical ADME (DMPK) • Pathology & Toxicology • Clinical Pharmacology • Clinical Trial Design and Data Management • Business Development • Licensing, Alliance Management (JVs), M&A • Medical Writing and Medical Communication

  17. DIVERSE CAREER OPPORTUNITIES II • Lab Automation • Product Formulation and Drug Delivery • Biostatistics • Scientific, Clinical, Medical Affairs • Medical Science Liaison (MSL); Identify KOLs • Competitive Medical & Scientific Intelligence • Technology Transfer; Identify & Interact with CROs • Regulatory Affairs Worldwide, e.g., FDA • Drug Safety (Pharmacovigilence) • QA/QC; Manufacturing; Process Development

  18. INTERVIEWING TIPS FOR SUCCESS • Prepare, Prepare, Prepare • Research the Company and the Key Players • Be Aware of Your Strengths and Weaknesses • Differentiate Yourself, e.g., Experience, Expertise, and Accomplishments • Demonstrate Evidence That You Meet the Job Specs • Focus on Quantifiable, Specific Actions & Results • Tailor Responses to the Job Opportunity • Show Interest and Enthusiasm • Demonstrate Likability and Competency

  19. SUMMARY • Role, mission and strategy of the industry • Complex, risky, costly, highly-regulated industry • Are there differences from an academic career? • Put to rest common myths and misconceptions • Cutting-edge drug design technological advances • Industry values and operating principles • Potential candidates and core skills • Diversity of career opportunities in the industry • Richly rewarding noble profession!

More Related